��������

Dr. Cantillon brings over 25 years of experience leading clinical development programs from AstraZeneca, Pfizer and Merck. Most recently, he was Chief Medical Officer of Reviva Pharmaceuticals and prior to this, Chief Medical Officer of Green Valley Pharmaceuticals. Dr. Cantillon was also the founding Executive Medical Director of the CAMD (Coalition Against Major Diseases) at the FDA-partnership Critical Path Institute. He received his MD medical degree from Karolinska Institute, Stockholm, specialty training internal medicine, psychiatry and geriatrics at Cornell and Mount Sinai New York and neuropsychopharmacology at NIH. Dr. Cantillon completed Business Administration courses at Wharton School, University of Pennsylvania.